Jamjoom Pharma has released its inaugural Sustainability Report for the fiscal year ending December 31, 2024, introducing its first formal materiality assessment and sustainability framework. The report outlines a structured approach to integrating ESG priorities into both corporate strategy and daily operations, aligned with Global Reporting Initiative (GRI) standards.
It showcases progress across four strategic pillars—including expanding affordable regional access to healthcare, enhancing employee well‑being and training, optimizing resource efficiency, and strengthening governance for transparency and accountability.
This launch marks a pivotal milestone in Jamjoom Pharma’s sustainability journey, signaling its commitment to responsible growth, stakeholder value, and long‑term ESG performance.
